
Medium Biosciences
Medium Biosciences is a YC Summer 2021 (S21) company. Based in San Francisco, CA, USA. Team of 6.
About Medium Biosciences
Summary
Medium Biosciences designs and delivers custom affinity reagents, using AI and protein engineering to produce experimentally validated molecular tools for research teams and diagnostic developers. It replaces the slow, generalist process of sourcing or developing binding proteins in-house, delivering validated reagents tailored to a specific target and application in weeks rather than months.
Business model
Per-project fee for custom affinity reagent design and delivery.
Go-to-market
Customers, spanning academic labs and industry diagnostics teams, initiate projects by describing their target molecule, after which Medium Biosciences scopes and executes the custom reagent build on demand.
From the Y Combinator listing
AI-designed Protein Therapeutics
We develop AI models & new assays to create functional, therapeutic proteins.
Facts
- Healthcare / Healthcare -> Therapeutics
- San Francisco, CA, USA
- 6
- Active
- Early
Founders (2)
- Adil Yusuf
- Mohamed Hassan Kane
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works